Home | All trials

[RDF data]
Trial NCT00000259

Resource URI: http://static.linkedct.org/resource/trials/NCT00000259
PropertyValue
linkedct:brief_title Sevoflurane Vs Isoflurane Inhalation at Subanesthetic Concentrations - 11
linkedct:collaborator_agency <http://static.linkedct.org/resource/collabagency/8705>
linkedct:condition <http://static.linkedct.org/resource/condition/12664>
linkedct:condition <http://static.linkedct.org/resource/condition/9249>
linkedct:criteria Please contact site for information.
linkedct:download_date Information obtained from ClinicalTrials.gov on December 30, 2009
linkedct:eligibility_gender Both
linkedct:eligibility_healthy_volunteers No
linkedct:eligibility_maximum_age 39 Years
linkedct:eligibility_minimum_age 21 Years
linkedct:enrollment 0 (xsd:int)
linkedct:firstreceived_date September 20, 1999
linkedct:id NCT00000259
rdfs:label Trial NCT00000259
linkedct:lastchanged_date June 23, 2005
linkedct:lead_sponsor_agency National Institute on Drug Abuse (NIDA)
linkedct:location <http://static.linkedct.org/resource/location/193133>
linkedct:nct_id NCT00000259
linkedct:number_of_arms 0 (xsd:int)
linkedct:number_of_groups 0 (xsd:int)
linkedct:official_title Sevoflurane Vs Isoflurane Inhalation at Subanesthetic Concentrations
linkedct:org_study_id NIDA-08391-11
linkedct:overall_official <http://static.linkedct.org/resource/overall_official/25443>
linkedct:overall_status Completed
linkedct:oversight <http://static.linkedct.org/resource/oversight/2918>
foaf:page <http://clinicaltrials.gov/show/NCT00000259>
linkedct:phase Phase 2
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/13199>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/15141>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/15159>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/15909>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/17498>
linkedct:primary_outcomes <http://static.linkedct.org/resource/primary_outcomes/4896>
linkedct:secondary_id R01-08391-11
linkedct:source National Institute on Drug Abuse (NIDA)
linkedct:start_date August 1996
linkedct:study_design Treatment
linkedct:study_type Interventional
linkedct:summary The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To examine sevoflurane versus isoflurane inhalation at subanesthetic concentrations on mood, pain, and psychomotor performance.
rdf:type linkedct:trials
linkedct:verification_date November 1996